Woodford Investment Management as of Sept. 30, 2016
Portfolio Holdings for Woodford Investment Management
Woodford Investment Management holds 8 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 28.1 | $696M | 11M | 63.07 | |
| Prothena (PRTA) | 25.0 | $617M | 10M | 59.93 | |
| Reynolds American | 14.5 | $359M | 7.6M | 47.15 | |
| Alkermes (ALKS) | 14.3 | $355M | 7.5M | 47.03 | |
| Theravance Biopharma (TBPH) | 13.8 | $341M | 9.4M | 36.24 | |
| Biogen Idec (BIIB) | 2.2 | $53M | 170k | 313.03 | |
| Gilead Sciences (GILD) | 1.6 | $39M | 487k | 79.12 | |
| Northwest Biotherapeutics In (NWBO) | 0.6 | $14M | 26M | 0.54 |
